T1	Participants 0 111	Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm
T2	Participants 237 321	treatment of hepatocellular carcinoma (HCC) ≤ 4 cm, in patients with liver cirrhosis
T3	Participants 445 478	15 patients were treated with PLA
T4	Participants 570 603	15 patients were treated with RFA
T5	Participants 643 688	Patients were followed up for up to 12 months
T6	Participants 908 985	a higher rate of recurrence was observed in the PLA group for lesions ≥ 21 mm
T7	Participants 1000 1053	A postablation syndrome was documented in 13 patients
